{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-021948","form_type":"8-K","ticker":"LMFA","cik":"0001640384","company_name":"LM FUNDING AMERICA, INC.","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.532419+00:00","generated_at":"2026-06-22T09:16:54.052546+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"LMFA SPAC completes business combination with SeaStar Medical; notes amended","bullets":["LMAO merged with SeaStar Medical, renamed SeaStar Medical Holding Corp.; trades as ICU/ICUCW starting Oct 31.","LMFAO Sponsor consolidated two notes into $2.785M note; LMFA amended $700K SeaStar note; both at 7% interest, due Oct 2023.","Notes secured by assets of SMHC and SeaStar Medical; customary covenants and events of default.","SeaStar Medical submitted HDE application for pediatric SCD; plans adult AKI pivotal study in Q1 2023.","Transaction approved by >96% of LMAO stockholder votes cast."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-021948","json":"https://secwatch.observer/filing/0000950170-22-021948.json","markdown":"https://secwatch.observer/filing/0000950170-22-021948.md","text":"https://secwatch.observer/filing/0000950170-22-021948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/lmfa-20221028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T09:16:54.052546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68ff9a2fbb1f1e3419715f96c4d493b3eaa31b4d","claim":"LM FUNDING AMERICA, INC. entered into Agreement and Plan of Merger with LMF Merger Sub, Inc. and SeaStar Medical, Inc. (effective 2022-04-21).","evidence_excerpt":"that certain Agreement and Plan of Merger (the “ Merger Agreement ”), dated April 21, 2022, by and among LMAO, LMF Merger Sub, Inc., a Delaware corporation and direct wholly owned subsidiary of LMAO (“ Merger Sub ”), and SeaStar Medical, Inc., a Delaware corporation (“ SeaStar Medical ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"LMF Merger Sub, Inc. and SeaStar Medical, Inc."},{"label":"Effective","value":"2022-04-21"}],"fact_type":"material_agreement"},{"claim_id":"6b4b5d2443547d3c7039fda4b04219193786f7dd","claim":"LM FUNDING AMERICA, INC. amended Amended LMFA Note with LM Funding America, Inc. and SeaStar Medical, Inc. valued at $700,000 (effective 2022-10-28).","evidence_excerpt":"LMFA and SeaStar Medical amended and restated the original Promissory Note, dated September 9, 2022, issued by SeaStar Medical to LMFA in the principal amount of $700,000 (the “ Original LMFA Note ”), by entering into an amended and restated promissory note (the “ Amended LMFA Note ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"LM Funding America, Inc. and SeaStar Medical, Inc."},{"label":"Value","value":"$700,000"},{"label":"Effective","value":"2022-10-28"}],"fact_type":"material_agreement"},{"claim_id":"bf22c4bb8aaee7e424883ba3d30da87d07e71e4b","claim":"LM FUNDING AMERICA, INC. amended Amended Sponsor Note with LMFAO Sponsor, LLC and SeaStar Medical Holdings Corporation valued at $2,785,000 (effective 2022-10-28).","evidence_excerpt":"Sponsor and SMHC amended, restated, and consolidated (i) the original Promissory Note, dated July 29, 2022, issued by LMAO to Sponsor in the principal amount of $1,035,000 and (ii) the original Amended and Restated Promissory Note, effective June 30, 2022, issued by LMAO to Sponsor in the principal amount of $1,750,000 (collectively, the “ Original Sponsor Notes ”), by entering into one consolidated amended and restated promissory note with an aggregate principal amount of $2,785,000 (the “ Amended Sponsor Note ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1640384/000095017022021948/0000950170-22-021948-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"LMFAO Sponsor, LLC and SeaStar Medical Holdings Corporation"},{"label":"Value","value":"$2,785,000"},{"label":"Effective","value":"2022-10-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}